Signase
Latest round
- Seed
Last raised
- May 2000
Total raised
- Undisclosed
Investors
- 3
About Signase
Based in US, Signase is a biopharmaceuticals company. It focuses on the development of inhibitors of protein tyrosine kinases.
Who invested in Signase
3 investors across 1 round
See all investors in Signase
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 1, 2000
Amount
Undisclosed
Investors
Questions about Signase
Who invested in Signase?
Signase has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Signase raised?
Signase has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Signase last raise money?
Signase's most recent round on record is a Seed, in May 2000.
What does Signase do?
Based in US, Signase is a biopharmaceuticals company.
Where is Signase headquartered?
Signase is headquartered in Houston, US.
Which VCs invest in companies like Signase?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Signase's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Signase? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.